{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:22:34Z","timestamp":1785507754342,"version":"3.56.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,10,15]]},"DOI":"10.1097\/01.tp.0000235545.49391.1b","type":"journal-article","created":{"date-parts":[[2006,10,10]],"date-time":"2006-10-10T10:15:02Z","timestamp":1160475302000},"page":"908-912","source":"Crossref","is-referenced-by-count":63,"title":["Sirolimus Interferes with Iron Homeostasis in Renal Transplant Recipients"],"prefix":"10.1097","volume":"82","author":[{"given":"Annamaria","family":"Maiorano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Stallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Schena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Infante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Pontrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"Schena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Grandaliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210129","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/01.ASN.0000125551.59739.2E","article-title":"Pharmacoepidemiology of anemia in kidney transplant recipients.","volume":"15","author":"Winkelmayer","year":"2004","journal-title":"J Soc Am Nephrol"},{"key":"R2-9-20210129","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1399-0012.1994.tb00377.x","article-title":"Factors affecting erythropoietin production and correction of anemia in kidney transplant recipients.","volume":"8","author":"Moore","year":"1994","journal-title":"Clin Transplant"},{"key":"R3-9-20210129","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1046\/j.1600-6135.2003.00224.x","article-title":"Anemia: a continuing problem following kidney transplantation.","volume":"3","author":"Mix","year":"2003","journal-title":"Am J Transplant"},{"key":"R4-9-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1523-1755.2001.00460.x","article-title":"Sirolimus in transplantation: a review of the evidence.","volume":"59","author":"Saunders","year":"2001","journal-title":"Kidney Int"},{"key":"R5-9-20210129","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0009-9120(98)00048-4","article-title":"Sirolimus: distribution, pharmacokinetics and therapeutic range investigation: an update.","volume":"31","author":"Trepanier","year":"1998","journal-title":"Clin Biochem"},{"key":"R6-9-20210129","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ndt\/16.1.18","article-title":"Sirolimus: a new promising immunosuppressive drug. Towards a rationale for its use in renal transplantation.","volume":"16","author":"Morelon","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R7-9-20210129","first-page":"145","article-title":"The development of sirolimus: the University of Texas-Houston experience.","volume":"18","author":"Kahan","year":"2000","journal-title":"Clin Transplant"},{"key":"R8-9-20210129","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/01.tp.0000179106.07382.6a","article-title":"Anemia after late introduction of sirolimus may correlate with biochemical evidence of a chronic inflammatory state.","volume":"80","author":"Thaunat","year":"2005","journal-title":"Transplantation"},{"key":"R9-9-20210129","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease.","volume":"352","author":"Weiss","year":"2005","journal-title":"N Engl J Med"},{"key":"R10-9-20210129","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1182\/blood-2003-03-0672","article-title":"Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation.","volume":"102","author":"Ganz","year":"2003","journal-title":"Blood"},{"issue":"Suppl 4","key":"R11-9-20210129","first-page":"20","article-title":"European best practice guidelines 6\u20138: assessing and optimizing iron stores.","volume":"15","author":"Macdougall","year":"2000","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 4","key":"R12-9-20210129","first-page":"48","article-title":"European best practice guidelines for renal transplantation. Section IV. Long-term management of the transplant recipient. IV. 91 Haematological complications.","volume":"17","year":"2002","journal-title":"Anaemia Nephrol Dial Transplant"},{"key":"R13-9-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A worldwide, phase III, randomised, controlled, safety and efficacy study of sirolimus\/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts.","volume":"71","author":"Macdonald","year":"2001","journal-title":"Transplantation"},{"key":"R14-9-20210129","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00007890-199904150-00017","article-title":"Sirolimus (sirolimus)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group.","volume":"69","author":"Groth","year":"1999","journal-title":"Transplantation"},{"key":"R15-9-20210129","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/00007890-200004150-00009","article-title":"Sirolimus in association with Mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.","volume":"69","author":"Kreis","year":"2000","journal-title":"Transplantation"},{"key":"R16-9-20210129","doi-asserted-by":"crossref","first-page":"G403","DOI":"10.1152\/ajpgi.00404.2001","article-title":"Physiology of iron transport and the hemocromatosis gene.","volume":"282","author":"Pietrangelo","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R17-9-20210129","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates iron efflux by binding to ferroportin and inducing its internalization.","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"R18-9-20210129","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0268-960X(03)00066-3","article-title":"Hepcidin and anemia.","volume":"18","author":"Means","year":"2004","journal-title":"Blood Rev"},{"key":"R19-9-20210129","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.","volume":"113","author":"Nemeth","year":"2004","journal-title":"J Clin Invest"},{"key":"R20-9-20210129","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0092-8674(00)00117-3","article-title":"TOR, a central controller of cell growth.","volume":"103","author":"Schmelzle","year":"2000","journal-title":"Cell"},{"key":"R21-9-20210129","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1073\/pnas.121145898","article-title":"The target of sirolimus (TOR) proteins.","volume":"98","author":"Raught","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R22-9-20210129","doi-asserted-by":"crossref","first-page":"7772","DOI":"10.1073\/pnas.95.13.7772","article-title":"Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of sirolimus mediated by a protein kinase B signaling pathway.","volume":"95","author":"Scott","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"R23-9-20210129","first-page":"3504","article-title":"A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of sirolimus in mitogen-stimulated and transformed cells.","volume":"60","author":"Sekulic","year":"2000","journal-title":"Cancer Res"},{"key":"R24-9-20210129","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.98.1.136","article-title":"A role of the kinase mTOR in cellular transformation induced by the oncoproteins PI3k and Akt.","volume":"98","author":"Aoki","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R25-9-20210129","doi-asserted-by":"crossref","first-page":"10314","DOI":"10.1073\/pnas.171076798","article-title":"Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP\/mTOR.","volume":"98","author":"Neshat","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R26-9-20210129","doi-asserted-by":"crossref","first-page":"10320","DOI":"10.1073\/pnas.171060098","article-title":"An inhibitor of mTOR reduces neoplasia and normalizes p70\/S6 kinase activity in Pten+\/\u2212 mice.","volume":"98","author":"Podsypanina","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R27-9-20210129","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1091\/mbc.01-12-0584","article-title":"Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake.","volume":"13","author":"Edinger","year":"2002","journal-title":"Mol Biol Cell"},{"key":"R28-9-20210129","doi-asserted-by":"crossref","first-page":"6924","DOI":"10.1093\/emboj\/17.23.6924","article-title":"The TOR nutrient signaling pathway phosphorylates NPR1 and inhibits turnover of the tryptophan permease.","volume":"17","author":"Schmidt","year":"1998","journal-title":"EMBO J"},{"key":"R29-9-20210129","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1083\/jcb.146.6.1227","article-title":"Starvation induces vacuolar targeting and degradation of the tryptophan permease in yeast.","volume":"146","author":"Beck","year":"1999","journal-title":"J Cell Biol"},{"key":"R30-9-20210129","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S1357-2725(01)00063-2","article-title":"Chemistry and biology of eukaryotic iron metabolism.","volume":"33","author":"Aisen","year":"2001","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007890-200610150-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T09:51:33Z","timestamp":1736589093000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-200610150-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,15]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000235545.49391.1b","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10,15]]}}}